Measurable Residual Disease Negativity Tied to Survival in AML

THURSDAY, Oct. 8, 2020 -- For patients with acute myeloid leukemia (AML), achieving measurable residual disease (MRD) negativity is associated with improved survival, according to a review and meta-analysis published online Oct. 8 in JAMA...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news